This Week Health
SUBSCRIBE NOW to receive top 7 stories daily to your inbox
<--  All Stories

New FDA-approved drug makes severe food allergies less life-threatening

February 19, 2024
Ars Technica
Contributed by: Reid Stephan
Summary
FDA approves Omalizumab (Xolair) to reduce food allergy reactions. Effective in trial subjects with multiple allergies, blocks allergic responses by binding immunoglobulin E. Not universal cure, continued vigilance required. Long-term effectiveness and combination with oral immunotherapy being researched. Side effects include injection reactions, fever, potential pain, infections, malignancies.
Transform Healthcare - One Connection at a Time

© Copyright 2023 Health Lyrics All rights reserved